Palvella Therapeutics Statistics
Total Valuation
PVLA has a market cap or net worth of $215.67 million. The enterprise value is $225.54 million.
| Market Cap | 215.67M |
| Enterprise Value | 225.54M |
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PVLA has 11.22 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 11.22M |
| Shares Outstanding | 11.22M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 17.63% |
| Owned by Institutions (%) | 5.81% |
| Float | 6.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -12.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14
| Current Ratio | 2.14 |
| Quick Ratio | 1.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -128.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 67.59 |
| Average Volume (20 Days) | 49,771 |
Short Selling Information
The latest short interest is 17,355, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 17,355 |
| Short Previous Month | 13,312 |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.15M |
| Pretax Income | n/a |
| Net Income | -7.75M |
| EBITDA | n/a |
| EBIT | -11.15M |
| Earnings Per Share (EPS) | -$1.36 |
Balance Sheet
The company has $14.21 million in cash and $24.07 million in debt, giving a net cash position of -$9.86 million or -$0.88 per share.
| Cash & Cash Equivalents | 14.21M |
| Total Debt | 24.07M |
| Net Cash | -9.86M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | -16.80M |
| Book Value Per Share | -15.28 |
| Working Capital | 8.69M |
Cash Flow
| Operating Cash Flow | -7.87M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.87M |
| FCF Per Share | -$0.70 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PVLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | -3.59% |
| FCF Yield | -3.65% |
Analyst Forecast
The average price target for PVLA is $40.33, which is 109.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.33 |
| Price Target Difference | 109.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |